JP2011525798A

JP2011525798A - 歯髄類似細胞（ｄｐｍｓｃ）ならびにその単離および使用の方法

歯髄類似細胞（ｄｐｍｓｃ）ならびにその単離および使用の方法 Download PDF

Info

Publication number: JP2011525798A
Authority: JP; Japan
Prior art keywords: cells; dpmsc; population; cell; differentiation
Prior art date: 2008-06-26
Legal status : Pending

Application number

JP2011515396A

Other languages

English (en)

Japanese (ja)

Other versions

JP2011525798A5 (https=

Inventor

フェデリコフェッロ，

Original Assignee

ウニベルシタデグリストゥディディウディネ

Priority date

2008-06-26

Filing date

2009-06-26

Publication date

2011-09-29

2009-06-26 Application filed by ウニベルシタデグリストゥディディウディネ filed Critical ウニベルシタデグリストゥディディウディネ

2011-09-29 Publication of JP2011525798A publication Critical patent/JP2011525798A/ja

2012-08-09 Publication of JP2011525798A5 publication Critical patent/JP2011525798A5/ja

Status Pending legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 151
238000002955 isolation Methods 0.000 title description 2
102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 claims abstract description 52
101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 claims abstract description 52
101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 claims abstract description 33
101100257363 Mus musculus Sox2 gene Proteins 0.000 claims abstract description 33
108010029485 Protein Isoforms Proteins 0.000 claims abstract description 23
102000001708 Protein Isoforms Human genes 0.000 claims abstract description 23
102100032912 CD44 antigen Human genes 0.000 claims abstract description 21
101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims abstract description 21
101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims abstract description 21
101000800116 Homo sapiens Thy-1 membrane glycoprotein Proteins 0.000 claims abstract description 21
102100025304 Integrin beta-1 Human genes 0.000 claims abstract description 21
102100033523 Thy-1 membrane glycoprotein Human genes 0.000 claims abstract description 21
102100022464 5'-nucleotidase Human genes 0.000 claims abstract description 20
102100022749 Aminopeptidase N Human genes 0.000 claims abstract description 20
102100022002 CD59 glycoprotein Human genes 0.000 claims abstract description 20
102100037241 Endoglin Human genes 0.000 claims abstract description 20
101000678236 Homo sapiens 5'-nucleotidase Proteins 0.000 claims abstract description 20
101000757160 Homo sapiens Aminopeptidase N Proteins 0.000 claims abstract description 20
101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 claims abstract description 20
101000881679 Homo sapiens Endoglin Proteins 0.000 claims abstract description 20
101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 claims abstract description 20
101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 claims abstract description 20
102100025323 Integrin alpha-1 Human genes 0.000 claims abstract description 20
102100032818 Integrin alpha-4 Human genes 0.000 claims abstract description 20
102000003729 Neprilysin Human genes 0.000 claims abstract description 20
108090000028 Neprilysin Proteins 0.000 claims abstract description 20
210000003716 mesoderm Anatomy 0.000 claims abstract description 19
210000001900 endoderm Anatomy 0.000 claims abstract description 15
210000003981 ectoderm Anatomy 0.000 claims abstract description 13
230000001133 acceleration Effects 0.000 claims abstract description 4
210000004027 cell Anatomy 0.000 claims description 646
230000004069 differentiation Effects 0.000 claims description 156
238000011282 treatment Methods 0.000 claims description 43
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 40
-1 Nanog Proteins 0.000 claims description 39
210000004413 cardiac myocyte Anatomy 0.000 claims description 37
210000002569 neuron Anatomy 0.000 claims description 35
239000003102 growth factor Substances 0.000 claims description 33
210000002966 serum Anatomy 0.000 claims description 33
210000000056 organ Anatomy 0.000 claims description 30
230000012010 growth Effects 0.000 claims description 28
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
210000000963 osteoblast Anatomy 0.000 claims description 25
238000012258 culturing Methods 0.000 claims description 23
210000003074 dental pulp Anatomy 0.000 claims description 23
108020004999 messenger RNA Proteins 0.000 claims description 22
230000001225 therapeutic effect Effects 0.000 claims description 21
102000004877 Insulin Human genes 0.000 claims description 20
108090001061 Insulin Proteins 0.000 claims description 20
229940125396 insulin Drugs 0.000 claims description 20
108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 19
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 17
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 17
238000004113 cell culture Methods 0.000 claims description 17
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 15
229960003957 dexamethasone Drugs 0.000 claims description 15
210000002919 epithelial cell Anatomy 0.000 claims description 15
210000004185 liver Anatomy 0.000 claims description 15
239000000126 substance Substances 0.000 claims description 15
102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 14
101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 14
102000013275 Somatomedins Human genes 0.000 claims description 14
210000004498 neuroglial cell Anatomy 0.000 claims description 14
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 14
229960005070 ascorbic acid Drugs 0.000 claims description 13
210000002950 fibroblast Anatomy 0.000 claims description 12
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 10
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 10
235000020778 linoleic acid Nutrition 0.000 claims description 10
210000000329 smooth muscle myocyte Anatomy 0.000 claims description 10
102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 9
108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 9
210000002744 extracellular matrix Anatomy 0.000 claims description 9
101800003838 Epidermal growth factor Proteins 0.000 claims description 8
101710150336 Protein Rex Proteins 0.000 claims description 8
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 8
102000004338 Transferrin Human genes 0.000 claims description 8
108090000901 Transferrin Proteins 0.000 claims description 8
229940116977 epidermal growth factor Drugs 0.000 claims description 8
239000011669 selenium Substances 0.000 claims description 8
229910052711 selenium Inorganic materials 0.000 claims description 8
210000002363 skeletal muscle cell Anatomy 0.000 claims description 8
239000000758 substrate Substances 0.000 claims description 8
239000012581 transferrin Substances 0.000 claims description 8
108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 7
102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 7
235000010323 ascorbic acid Nutrition 0.000 claims description 7
239000011668 ascorbic acid Substances 0.000 claims description 7
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 6
239000002211 L-ascorbic acid Substances 0.000 claims description 6
235000000069 L-ascorbic acid Nutrition 0.000 claims description 6
102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 6
101710135898 Myc proto-oncogene protein Proteins 0.000 claims description 6
101710150448 Transcriptional regulator Myc Proteins 0.000 claims description 6
210000004153 islets of langerhan Anatomy 0.000 claims description 6
230000001464 adherent effect Effects 0.000 claims description 5
210000002449 bone cell Anatomy 0.000 claims description 5
238000012217 deletion Methods 0.000 claims description 5
230000037430 deletion Effects 0.000 claims description 5
230000002779 inactivation Effects 0.000 claims description 5
101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 claims description 4
102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 claims description 4
210000003298 dental enamel Anatomy 0.000 claims description 4
210000004268 dentin Anatomy 0.000 claims description 4
210000003890 endocrine cell Anatomy 0.000 claims description 4
210000002615 epidermis Anatomy 0.000 claims description 4
210000004920 epithelial cell of skin Anatomy 0.000 claims description 4
210000002907 exocrine cell Anatomy 0.000 claims description 4
210000003780 hair follicle Anatomy 0.000 claims description 4
210000002490 intestinal epithelial cell Anatomy 0.000 claims description 4
210000005087 mononuclear cell Anatomy 0.000 claims description 4
230000009996 pancreatic endocrine effect Effects 0.000 claims description 4
229940091258 selenium supplement Drugs 0.000 claims description 4
210000004872 soft tissue Anatomy 0.000 claims description 4
102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 3
102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 3
102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 3
108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 3
102100025470 Carcinoembryonic antigen-related cell adhesion molecule 8 Human genes 0.000 claims description 3
108091005250 Glycophorins Proteins 0.000 claims description 3
101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 3
101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 3
101000914320 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 8 Proteins 0.000 claims description 3
230000001413 cellular effect Effects 0.000 claims description 3
238000012136 culture method Methods 0.000 claims description 3
238000003780 insertion Methods 0.000 claims description 3
230000037431 insertion Effects 0.000 claims description 3
102000009024 Epidermal Growth Factor Human genes 0.000 claims 1
102100035716 Glycophorin-A Human genes 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 description 108
230000014509 gene expression Effects 0.000 description 102
210000000130 stem cell Anatomy 0.000 description 90
239000002609 medium Substances 0.000 description 83
210000001519 tissue Anatomy 0.000 description 83
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 59
108020004414 DNA Proteins 0.000 description 54
239000013598 vector Substances 0.000 description 52
102000004169 proteins and genes Human genes 0.000 description 48
201000010099 disease Diseases 0.000 description 44
238000002054 transplantation Methods 0.000 description 37
230000006698 induction Effects 0.000 description 32
239000000427 antigen Substances 0.000 description 29
108091007433 antigens Proteins 0.000 description 28
102000036639 antigens Human genes 0.000 description 28
210000005036 nerve Anatomy 0.000 description 27
230000001537 neural effect Effects 0.000 description 26
102000007469 Actins Human genes 0.000 description 24
108010085238 Actins Proteins 0.000 description 24
210000001185 bone marrow Anatomy 0.000 description 24
206010028980 Neoplasm Diseases 0.000 description 23
230000000694 effects Effects 0.000 description 22
238000001415 gene therapy Methods 0.000 description 22
210000003958 hematopoietic stem cell Anatomy 0.000 description 22
230000035755 proliferation Effects 0.000 description 22
238000000338 in vitro Methods 0.000 description 21
230000001965 increasing effect Effects 0.000 description 21
102000053171 Glial Fibrillary Acidic Human genes 0.000 description 20
101710193519 Glial fibrillary acidic protein Proteins 0.000 description 20
210000005046 glial fibrillary acidic protein Anatomy 0.000 description 20
210000002027 skeletal muscle Anatomy 0.000 description 20
238000010186 staining Methods 0.000 description 20
230000001939 inductive effect Effects 0.000 description 19
239000003550 marker Substances 0.000 description 19
230000001177 retroviral effect Effects 0.000 description 19
241001465754 Metazoa Species 0.000 description 18
210000003494 hepatocyte Anatomy 0.000 description 18
238000001727 in vivo Methods 0.000 description 18
101150118570 Msx2 gene Proteins 0.000 description 17
210000000988 bone and bone Anatomy 0.000 description 17
239000000047 product Substances 0.000 description 17
201000011510 cancer Diseases 0.000 description 16
239000003814 drug Substances 0.000 description 16
238000010166 immunofluorescence Methods 0.000 description 16
210000003205 muscle Anatomy 0.000 description 16
239000013612 plasmid Substances 0.000 description 16
238000012546 transfer Methods 0.000 description 16
102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 15
108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 15
229940077737 brain-derived neurotrophic factor Drugs 0.000 description 15
210000005044 neurofilament Anatomy 0.000 description 15
229960005486 vaccine Drugs 0.000 description 15
102000004127 Cytokines Human genes 0.000 description 14
108090000695 Cytokines Proteins 0.000 description 14
206010071602 Genetic polymorphism Diseases 0.000 description 14
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 14
230000008901 benefit Effects 0.000 description 14
208000035475 disorder Diseases 0.000 description 14
210000001671 embryonic stem cell Anatomy 0.000 description 14
230000006870 function Effects 0.000 description 14
239000008103 glucose Substances 0.000 description 14
230000028993 immune response Effects 0.000 description 14
210000001178 neural stem cell Anatomy 0.000 description 14
108010088373 Neurofilament Proteins Proteins 0.000 description 13
102000008763 Neurofilament Proteins Human genes 0.000 description 13
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 13
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 13
239000003124 biologic agent Substances 0.000 description 13
229940079593 drug Drugs 0.000 description 13
230000002068 genetic effect Effects 0.000 description 13
239000000203 mixture Substances 0.000 description 13
230000002062 proliferating effect Effects 0.000 description 13
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 12
102000004190 Enzymes Human genes 0.000 description 12
108090000790 Enzymes Proteins 0.000 description 12
101100013973 Mus musculus Gata4 gene Proteins 0.000 description 12
108090000573 Osteocalcin Proteins 0.000 description 12
210000004369 blood Anatomy 0.000 description 12
239000008280 blood Substances 0.000 description 12
210000004556 brain Anatomy 0.000 description 12
230000024245 cell differentiation Effects 0.000 description 12
229940088598 enzyme Drugs 0.000 description 12
238000003119 immunoblot Methods 0.000 description 12
239000011159 matrix material Substances 0.000 description 12
208000015122 neurodegenerative disease Diseases 0.000 description 12
230000004031 neuronal differentiation Effects 0.000 description 12
239000002831 pharmacologic agent Substances 0.000 description 12
230000008439 repair process Effects 0.000 description 12
108010088751 Albumins Proteins 0.000 description 11
102000009027 Albumins Human genes 0.000 description 11
102000001045 Connexin 43 Human genes 0.000 description 11
108010069241 Connexin 43 Proteins 0.000 description 11
102000005604 Myosin Heavy Chains Human genes 0.000 description 11
108010084498 Myosin Heavy Chains Proteins 0.000 description 11
102000004067 Osteocalcin Human genes 0.000 description 11
102000040945 Transcription factor Human genes 0.000 description 11
108091023040 Transcription factor Proteins 0.000 description 11
229910002091 carbon monoxide Inorganic materials 0.000 description 11
238000005516 engineering process Methods 0.000 description 11
238000002347 injection Methods 0.000 description 11
239000007924 injection Substances 0.000 description 11
210000004940 nucleus Anatomy 0.000 description 11
208000024891 symptom Diseases 0.000 description 11
239000013603 viral vector Substances 0.000 description 11
238000001262 western blot Methods 0.000 description 11
102000013127 Vimentin Human genes 0.000 description 10
108010065472 Vimentin Proteins 0.000 description 10
239000012298 atmosphere Substances 0.000 description 10
210000000845 cartilage Anatomy 0.000 description 10
238000002659 cell therapy Methods 0.000 description 10
210000002460 smooth muscle Anatomy 0.000 description 10
108091035539 telomere Proteins 0.000 description 10
102000055501 telomere Human genes 0.000 description 10
210000003411 telomere Anatomy 0.000 description 10
108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
102100022146 Arylsulfatase A Human genes 0.000 description 9
102000012422 Collagen Type I Human genes 0.000 description 9
108010022452 Collagen Type I Proteins 0.000 description 9
241000282412 Homo Species 0.000 description 9
102000004264 Osteopontin Human genes 0.000 description 9
108010081689 Osteopontin Proteins 0.000 description 9
208000018737 Parkinson disease Diseases 0.000 description 9
102000004874 Synaptophysin Human genes 0.000 description 9
108090001076 Synaptophysin Proteins 0.000 description 9
210000001130 astrocyte Anatomy 0.000 description 9
230000036755 cellular response Effects 0.000 description 9
230000007423 decrease Effects 0.000 description 9
210000002257 embryonic structure Anatomy 0.000 description 9
238000002474 experimental method Methods 0.000 description 9
210000002901 mesenchymal stem cell Anatomy 0.000 description 9
210000004248 oligodendroglia Anatomy 0.000 description 9
239000002243 precursor Substances 0.000 description 9
210000005048 vimentin Anatomy 0.000 description 9
108010081589 Becaplermin Proteins 0.000 description 8
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
102000003745 Hepatocyte Growth Factor Human genes 0.000 description 8
108090000100 Hepatocyte Growth Factor Proteins 0.000 description 8
108010025020 Nerve Growth Factor Proteins 0.000 description 8
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 8
102000009890 Osteonectin Human genes 0.000 description 8
108010077077 Osteonectin Proteins 0.000 description 8
210000003169 central nervous system Anatomy 0.000 description 8
206010012601 diabetes mellitus Diseases 0.000 description 8
239000001963 growth medium Substances 0.000 description 8
210000000987 immune system Anatomy 0.000 description 8
238000004519 manufacturing process Methods 0.000 description 8
239000012528 membrane Substances 0.000 description 8
210000004379 membrane Anatomy 0.000 description 8
210000000663 muscle cell Anatomy 0.000 description 8
102000040430 polynucleotide Human genes 0.000 description 8
108091033319 polynucleotide Proteins 0.000 description 8
239000002157 polynucleotide Substances 0.000 description 8
238000002360 preparation method Methods 0.000 description 8
238000009256 replacement therapy Methods 0.000 description 8
230000004044 response Effects 0.000 description 8
208000020431 spinal cord injury Diseases 0.000 description 8
238000012289 standard assay Methods 0.000 description 8
238000001890 transfection Methods 0.000 description 8
230000009278 visceral effect Effects 0.000 description 8
102000002260 Alkaline Phosphatase Human genes 0.000 description 7
108020004774 Alkaline Phosphatase Proteins 0.000 description 7
102100021253 Antileukoproteinase Human genes 0.000 description 7
102400001368 Epidermal growth factor Human genes 0.000 description 7
108700018351 Major Histocompatibility Complex Proteins 0.000 description 7
241000124008 Mammalia Species 0.000 description 7
102000015336 Nerve Growth Factor Human genes 0.000 description 7
102100029268 Neurotrophin-3 Human genes 0.000 description 7
208000006011 Stroke Diseases 0.000 description 7
108010017842 Telomerase Proteins 0.000 description 7
108090000704 Tubulin Proteins 0.000 description 7
102000004243 Tubulin Human genes 0.000 description 7
230000003698 anagen phase Effects 0.000 description 7
238000003556 assay Methods 0.000 description 7
230000009286 beneficial effect Effects 0.000 description 7
210000002459 blastocyst Anatomy 0.000 description 7
239000002775 capsule Substances 0.000 description 7
239000004202 carbamide Substances 0.000 description 7
238000002512 chemotherapy Methods 0.000 description 7
210000002889 endothelial cell Anatomy 0.000 description 7
210000004165 myocardium Anatomy 0.000 description 7
230000037361 pathway Effects 0.000 description 7
210000001778 pluripotent stem cell Anatomy 0.000 description 7
230000008569 process Effects 0.000 description 7
102000005962 receptors Human genes 0.000 description 7
108020003175 receptors Proteins 0.000 description 7
239000000243 solution Substances 0.000 description 7
230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 7
230000009885 systemic effect Effects 0.000 description 7
238000012360 testing method Methods 0.000 description 7
102000010825 Actinin Human genes 0.000 description 6
108010063503 Actinin Proteins 0.000 description 6
208000024827 Alzheimer disease Diseases 0.000 description 6
101800001288 Atrial natriuretic factor Proteins 0.000 description 6
102400001282 Atrial natriuretic peptide Human genes 0.000 description 6
101800001890 Atrial natriuretic peptide Proteins 0.000 description 6
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 description 6
102100024506 Bone morphogenetic protein 2 Human genes 0.000 description 6
102000019034 Chemokines Human genes 0.000 description 6
108010012236 Chemokines Proteins 0.000 description 6
102000015775 Core Binding Factor Alpha 1 Subunit Human genes 0.000 description 6
108010024682 Core Binding Factor Alpha 1 Subunit Proteins 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 description 6
102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
102000003505 Myosin Human genes 0.000 description 6
108060008487 Myosin Proteins 0.000 description 6
102000008730 Nestin Human genes 0.000 description 6
108010088225 Nestin Proteins 0.000 description 6
108090000742 Neurotrophin 3 Proteins 0.000 description 6
RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 6
102000004142 Trypsin Human genes 0.000 description 6
108090000631 Trypsin Proteins 0.000 description 6
108091000117 Tyrosine 3-Monooxygenase Proteins 0.000 description 6
102000048218 Tyrosine 3-monooxygenases Human genes 0.000 description 6
230000005856 abnormality Effects 0.000 description 6
239000000654 additive Substances 0.000 description 6
230000000735 allogeneic effect Effects 0.000 description 6
238000004458 analytical method Methods 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
NSQLIUXCMFBZME-MPVJKSABSA-N carperitide Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 NSQLIUXCMFBZME-MPVJKSABSA-N 0.000 description 6
239000003153 chemical reaction reagent Substances 0.000 description 6
230000006378 damage Effects 0.000 description 6
210000003038 endothelium Anatomy 0.000 description 6
210000000981 epithelium Anatomy 0.000 description 6
238000001943 fluorescence-activated cell sorting Methods 0.000 description 6
210000004602 germ cell Anatomy 0.000 description 6
238000003364 immunohistochemistry Methods 0.000 description 6
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 6
239000002502 liposome Substances 0.000 description 6
230000004072 osteoblast differentiation Effects 0.000 description 6
238000004806 packaging method and process Methods 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
230000035752 proliferative phase Effects 0.000 description 6
238000011160 research Methods 0.000 description 6
238000003860 storage Methods 0.000 description 6
230000017423 tissue regeneration Effects 0.000 description 6
239000012588 trypsin Substances 0.000 description 6
SIAMJSNNNCYTRM-MGBGTMOVSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphosulfocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[S+](C)C)OC(=O)CCCCCCCCCCCCC SIAMJSNNNCYTRM-MGBGTMOVSA-N 0.000 description 5
102000029816 Collagenase Human genes 0.000 description 5
108060005980 Collagenase Proteins 0.000 description 5
102000010956 Glypican Human genes 0.000 description 5
108050001154 Glypican Proteins 0.000 description 5
102000009094 Hepatocyte Nuclear Factor 3-beta Human genes 0.000 description 5
108010087745 Hepatocyte Nuclear Factor 3-beta Proteins 0.000 description 5
208000023105 Huntington disease Diseases 0.000 description 5
208000026350 Inborn Genetic disease Diseases 0.000 description 5
102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 5
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
241000699670 Mus sp. Species 0.000 description 5
238000010240 RT-PCR analysis Methods 0.000 description 5
241000283984 Rodentia Species 0.000 description 5
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 5
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 5
241000700605 Viruses Species 0.000 description 5
239000001506 calcium phosphate Substances 0.000 description 5
229910000389 calcium phosphate Inorganic materials 0.000 description 5
235000011010 calcium phosphates Nutrition 0.000 description 5
229960002424 collagenase Drugs 0.000 description 5
150000001875 compounds Chemical class 0.000 description 5
230000002596 correlated effect Effects 0.000 description 5
210000004748 cultured cell Anatomy 0.000 description 5
230000003247 decreasing effect Effects 0.000 description 5
230000003412 degenerative effect Effects 0.000 description 5
230000013020 embryo development Effects 0.000 description 5
230000009395 genetic defect Effects 0.000 description 5
210000001654 germ layer Anatomy 0.000 description 5
208000019622 heart disease Diseases 0.000 description 5
230000002440 hepatic effect Effects 0.000 description 5
238000011534 incubation Methods 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
230000000670 limiting effect Effects 0.000 description 5
201000006417 multiple sclerosis Diseases 0.000 description 5
230000035772 mutation Effects 0.000 description 5
210000005055 nestin Anatomy 0.000 description 5
239000013641 positive control Substances 0.000 description 5
210000003491 skin Anatomy 0.000 description 5
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
208000023275 Autoimmune disease Diseases 0.000 description 4
201000004569 Blindness Diseases 0.000 description 4
208000031229 Cardiomyopathies Diseases 0.000 description 4
206010010356 Congenital anomaly Diseases 0.000 description 4
108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 4
102000003849 Cytochrome P450 Human genes 0.000 description 4
206010012689 Diabetic retinopathy Diseases 0.000 description 4
102000003951 Erythropoietin Human genes 0.000 description 4
108090000394 Erythropoietin Proteins 0.000 description 4
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 4
102100028072 Fibroblast growth factor 4 Human genes 0.000 description 4
108090000381 Fibroblast growth factor 4 Proteins 0.000 description 4
206010017076 Fracture Diseases 0.000 description 4
241000287828 Gallus gallus Species 0.000 description 4
102000034615 Glial cell line-derived neurotrophic factor Human genes 0.000 description 4
108091010837 Glial cell line-derived neurotrophic factor Proteins 0.000 description 4
229920002527 Glycogen Polymers 0.000 description 4
206010019280 Heart failures Diseases 0.000 description 4
108010066302 Keratin-19 Proteins 0.000 description 4
208000002678 Mucopolysaccharidoses Diseases 0.000 description 4
101150114527 Nkx2-5 gene Proteins 0.000 description 4
108091028043 Nucleic acid sequence Proteins 0.000 description 4
108010056088 Somatostatin Proteins 0.000 description 4
102000005157 Somatostatin Human genes 0.000 description 4
NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 4
239000004098 Tetracycline Substances 0.000 description 4
101100460507 Xenopus laevis nkx-2.5 gene Proteins 0.000 description 4
230000033115 angiogenesis Effects 0.000 description 4
239000003242 anti bacterial agent Substances 0.000 description 4
229940088710 antibiotic agent Drugs 0.000 description 4
239000002246 antineoplastic agent Substances 0.000 description 4
210000000601 blood cell Anatomy 0.000 description 4
210000004204 blood vessel Anatomy 0.000 description 4
238000010322 bone marrow transplantation Methods 0.000 description 4
230000000747 cardiac effect Effects 0.000 description 4
230000008859 change Effects 0.000 description 4
239000003795 chemical substances by application Substances 0.000 description 4
230000004186 co-expression Effects 0.000 description 4
229940127089 cytotoxic agent Drugs 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
235000021186 dishes Nutrition 0.000 description 4
210000005064 dopaminergic neuron Anatomy 0.000 description 4
229940105423 erythropoietin Drugs 0.000 description 4
230000001605 fetal effect Effects 0.000 description 4
208000016361 genetic disease Diseases 0.000 description 4
229940096919 glycogen Drugs 0.000 description 4
230000003394 haemopoietic effect Effects 0.000 description 4
238000013537 high throughput screening Methods 0.000 description 4
210000005260 human cell Anatomy 0.000 description 4
238000012744 immunostaining Methods 0.000 description 4
239000004615 ingredient Substances 0.000 description 4
208000014674 injury Diseases 0.000 description 4
238000011081 inoculation Methods 0.000 description 4
239000000463 material Substances 0.000 description 4
230000002025 microglial effect Effects 0.000 description 4
206010028093 mucopolysaccharidosis Diseases 0.000 description 4
230000002107 myocardial effect Effects 0.000 description 4
239000013642 negative control Substances 0.000 description 4
210000002241 neurite Anatomy 0.000 description 4
229960003966 nicotinamide Drugs 0.000 description 4
235000005152 nicotinamide Nutrition 0.000 description 4
239000011570 nicotinamide Substances 0.000 description 4
239000002773 nucleotide Substances 0.000 description 4
125000003729 nucleotide group Chemical group 0.000 description 4
201000008482 osteoarthritis Diseases 0.000 description 4
239000008194 pharmaceutical composition Substances 0.000 description 4
102000054765 polymorphisms of proteins Human genes 0.000 description 4
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
238000012216 screening Methods 0.000 description 4
229960000553 somatostatin Drugs 0.000 description 4
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 4
241000894007 species Species 0.000 description 4
229960002180 tetracycline Drugs 0.000 description 4
229930101283 tetracycline Natural products 0.000 description 4
235000019364 tetracycline Nutrition 0.000 description 4
150000003522 tetracyclines Chemical class 0.000 description 4
238000010257 thawing Methods 0.000 description 4
238000010361 transduction Methods 0.000 description 4
230000026683 transduction Effects 0.000 description 4
210000004881 tumor cell Anatomy 0.000 description 4
241001430294 unidentified retrovirus Species 0.000 description 4
210000004291 uterus Anatomy 0.000 description 4
230000003612 virological effect Effects 0.000 description 4
LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 3
108091006112 ATPases Proteins 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
102000057290 Adenosine Triphosphatases Human genes 0.000 description 3
102100036601 Aggrecan core protein Human genes 0.000 description 3
108010067219 Aggrecans Proteins 0.000 description 3
101710189683 Alkaline protease 1 Proteins 0.000 description 3
101710154562 Alkaline proteinase Proteins 0.000 description 3
101710170876 Antileukoproteinase Proteins 0.000 description 3
201000001320 Atherosclerosis Diseases 0.000 description 3
102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 3
208000010392 Bone Fractures Diseases 0.000 description 3
108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 3
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 3
102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 3
102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 3
239000004255 Butylated hydroxyanisole Substances 0.000 description 3
101710112538 C-C motif chemokine 27 Proteins 0.000 description 3
241000282472 Canis lupus familiaris Species 0.000 description 3
102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 3
102100022317 Dihydropteridine reductase Human genes 0.000 description 3
102100024785 Fibroblast growth factor 2 Human genes 0.000 description 3
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
208000001905 GM2 Gangliosidoses Diseases 0.000 description 3
201000008905 GM2 gangliosidosis Diseases 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
108091008603 HGF receptors Proteins 0.000 description 3
102100022623 Hepatocyte growth factor receptor Human genes 0.000 description 3
101001045440 Homo sapiens Beta-hexosaminidase subunit alpha Proteins 0.000 description 3
101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 3
102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 3
108010081823 Myocardin Proteins 0.000 description 3
102100030217 Myocardin Human genes 0.000 description 3
208000012902 Nervous system disease Diseases 0.000 description 3
102100032063 Neurogenic differentiation factor 1 Human genes 0.000 description 3
208000025966 Neurological disease Diseases 0.000 description 3
241000288906 Primates Species 0.000 description 3
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
210000001744 T-lymphocyte Anatomy 0.000 description 3
108700019146 Transgenes Proteins 0.000 description 3
102000004987 Troponin T Human genes 0.000 description 3
108090001108 Troponin T Proteins 0.000 description 3
241000251539 Vertebrata <Metazoa> Species 0.000 description 3
101710088929 Voltage-dependent L-type calcium channel subunit alpha-1S Proteins 0.000 description 3
238000002441 X-ray diffraction Methods 0.000 description 3
230000035508 accumulation Effects 0.000 description 3
238000009825 accumulation Methods 0.000 description 3
230000004913 activation Effects 0.000 description 3
238000004220 aggregation Methods 0.000 description 3
150000001413 amino acids Chemical group 0.000 description 3
230000000692 anti-sense effect Effects 0.000 description 3
230000005875 antibody response Effects 0.000 description 3
210000000612 antigen-presenting cell Anatomy 0.000 description 3
230000000975 bioactive effect Effects 0.000 description 3
210000002798 bone marrow cell Anatomy 0.000 description 3
235000019282 butylated hydroxyanisole Nutrition 0.000 description 3
239000000969 carrier Substances 0.000 description 3
230000032823 cell division Effects 0.000 description 3
230000010261 cell growth Effects 0.000 description 3
239000002771 cell marker Substances 0.000 description 3
210000001612 chondrocyte Anatomy 0.000 description 3
239000002299 complementary DNA Substances 0.000 description 3
230000001086 cytosolic effect Effects 0.000 description 3
230000007812 deficiency Effects 0.000 description 3
230000002950 deficient Effects 0.000 description 3
210000001968 dental pulp cell Anatomy 0.000 description 3
238000001514 detection method Methods 0.000 description 3
238000011161 development Methods 0.000 description 3
MWRBNPKJOOWZPW-CLFAGFIQSA-N dioleoyl phosphatidylethanolamine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(=O)OCCN)OC(=O)CCCCCCC\C=C/CCCCCCCC MWRBNPKJOOWZPW-CLFAGFIQSA-N 0.000 description 3
239000003937 drug carrier Substances 0.000 description 3
230000004064 dysfunction Effects 0.000 description 3
210000002308 embryonic cell Anatomy 0.000 description 3
230000003511 endothelial effect Effects 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
239000000835 fiber Substances 0.000 description 3
238000000684 flow cytometry Methods 0.000 description 3
210000002216 heart Anatomy 0.000 description 3
210000005003 heart tissue Anatomy 0.000 description 3
230000006801 homologous recombination Effects 0.000 description 3
238000002744 homologous recombination Methods 0.000 description 3
229910052588 hydroxylapatite Inorganic materials 0.000 description 3
239000007943 implant Substances 0.000 description 3
229960000905 indomethacin Drugs 0.000 description 3
239000012678 infectious agent Substances 0.000 description 3
239000003112 inhibitor Substances 0.000 description 3
229910052500 inorganic mineral Inorganic materials 0.000 description 3
210000003734 kidney Anatomy 0.000 description 3
208000036546 leukodystrophy Diseases 0.000 description 3
208000002780 macular degeneration Diseases 0.000 description 3
230000001404 mediated effect Effects 0.000 description 3
230000006371 metabolic abnormality Effects 0.000 description 3
208000030159 metabolic disease Diseases 0.000 description 3
239000011707 mineral Substances 0.000 description 3
208000010125 myocardial infarction Diseases 0.000 description 3
210000000944 nerve tissue Anatomy 0.000 description 3
210000000653 nervous system Anatomy 0.000 description 3
235000015097 nutrients Nutrition 0.000 description 3
230000011164 ossification Effects 0.000 description 3
239000002245 particle Substances 0.000 description 3
XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
229920001184 polypeptide Polymers 0.000 description 3
239000011148 porous material Substances 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
239000000186 progesterone Substances 0.000 description 3
229960003387 progesterone Drugs 0.000 description 3
238000001959 radiotherapy Methods 0.000 description 3
230000009467 reduction Effects 0.000 description 3
238000003757 reverse transcription PCR Methods 0.000 description 3
239000000523 sample Substances 0.000 description 3
229910052709 silver Inorganic materials 0.000 description 3
239000004332 silver Substances 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
238000011476 stem cell transplantation Methods 0.000 description 3
230000004936 stimulating effect Effects 0.000 description 3
238000001356 surgical procedure Methods 0.000 description 3
208000011580 syndromic disease Diseases 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
241000701161 unidentified adenovirus Species 0.000 description 3
241001529453 unidentified herpesvirus Species 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
238000002689 xenotransplantation Methods 0.000 description 3
SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
208000030507 AIDS Diseases 0.000 description 2
206010065040 AIDS dementia complex Diseases 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
102100029470 Apolipoprotein E Human genes 0.000 description 2
101710095339 Apolipoprotein E Proteins 0.000 description 2
206010003591 Ataxia Diseases 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
206010003694 Atrophy Diseases 0.000 description 2
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 description 2
108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
208000003174 Brain Neoplasms Diseases 0.000 description 2
102000000905 Cadherin Human genes 0.000 description 2
108050007957 Cadherin Proteins 0.000 description 2
102000055006 Calcitonin Human genes 0.000 description 2
108060001064 Calcitonin Proteins 0.000 description 2
208000022526 Canavan disease Diseases 0.000 description 2
241000282465 Canis Species 0.000 description 2
229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
201000009030 Carcinoma Diseases 0.000 description 2
208000024172 Cardiovascular disease Diseases 0.000 description 2
102000053642 Catalytic RNA Human genes 0.000 description 2
108090000994 Catalytic RNA Proteins 0.000 description 2
208000014912 Central Nervous System Infections Diseases 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
206010010099 Combined immunodeficiency Diseases 0.000 description 2
208000032170 Congenital Abnormalities Diseases 0.000 description 2
208000027205 Congenital disease Diseases 0.000 description 2
208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 description 2
108010072732 Core Binding Factors Proteins 0.000 description 2
102000006990 Core Binding Factors Human genes 0.000 description 2
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
238000000018 DNA microarray Methods 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
206010012667 Diabetic glaucoma Diseases 0.000 description 2
206010061818 Disease progression Diseases 0.000 description 2
206010013801 Duchenne Muscular Dystrophy Diseases 0.000 description 2
102100038595 Estrogen receptor Human genes 0.000 description 2
206010016077 Factor IX deficiency Diseases 0.000 description 2
241000282326 Felis catus Species 0.000 description 2
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
229930182566 Gentamicin Natural products 0.000 description 2
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
102000028180 Glycophorins Human genes 0.000 description 2
108060003393 Granulin Proteins 0.000 description 2
108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
208000032843 Hemorrhage Diseases 0.000 description 2
108010086524 Hepatocyte Nuclear Factor 4 Proteins 0.000 description 2
102000015902 Hepatocyte nuclear factor 4-alpha Human genes 0.000 description 2
102000009331 Homeodomain Proteins Human genes 0.000 description 2
108010048671 Homeodomain Proteins Proteins 0.000 description 2
206010020772 Hypertension Diseases 0.000 description 2
208000029462 Immunodeficiency disease Diseases 0.000 description 2
206010062016 Immunosuppression Diseases 0.000 description 2
206010022657 Intestinal infarction Diseases 0.000 description 2
208000012659 Joint disease Diseases 0.000 description 2
101710183399 Keratin, type I cytoskeletal 19 Proteins 0.000 description 2
102000004016 L-Type Calcium Channels Human genes 0.000 description 2
108090000420 L-Type Calcium Channels Proteins 0.000 description 2
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
208000034693 Laceration Diseases 0.000 description 2
241000713666 Lentivirus Species 0.000 description 2
102000008934 Muscle Proteins Human genes 0.000 description 2
108010074084 Muscle Proteins Proteins 0.000 description 2
208000009525 Myocarditis Diseases 0.000 description 2
108010056785 Myogenin Proteins 0.000 description 2
102100032970 Myogenin Human genes 0.000 description 2
108050000588 Neurogenic differentiation factor 1 Proteins 0.000 description 2
208000014060 Niemann-Pick disease Diseases 0.000 description 2
239000000020 Nitrocellulose Substances 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
108010016731 PPAR gamma Proteins 0.000 description 2
229930040373 Paraformaldehyde Natural products 0.000 description 2
102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 2
102100035846 Pigment epithelium-derived factor Human genes 0.000 description 2
108010076504 Protein Sorting Signals Proteins 0.000 description 2
241000700159 Rattus Species 0.000 description 2
201000007737 Retinal degeneration Diseases 0.000 description 2
206010038848 Retinal detachment Diseases 0.000 description 2
208000017442 Retinal disease Diseases 0.000 description 2
241000710960 Sindbis virus Species 0.000 description 2
241000282887 Suidae Species 0.000 description 2
206010042928 Syringomyelia Diseases 0.000 description 2
208000035896 Twin-reversed arterial perfusion sequence Diseases 0.000 description 2
238000008083 Urea Assay Methods 0.000 description 2
108010003533 Viral Envelope Proteins Proteins 0.000 description 2
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
PFRQBZFETXBLTP-UHFFFAOYSA-N Vitamin K2 Natural products C1=CC=C2C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C(=O)C2=C1 PFRQBZFETXBLTP-UHFFFAOYSA-N 0.000 description 2
208000026589 Wolman disease Diseases 0.000 description 2
208000027418 Wounds and injury Diseases 0.000 description 2
101710185494 Zinc finger protein Proteins 0.000 description 2
102100023597 Zinc finger protein 816 Human genes 0.000 description 2
HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical group CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
201000009628 adenosine deaminase deficiency Diseases 0.000 description 2
210000004504 adult stem cell Anatomy 0.000 description 2
229940072056 alginate Drugs 0.000 description 2
229920000615 alginic acid Polymers 0.000 description 2
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
208000006682 alpha 1-Antitrypsin Deficiency Diseases 0.000 description 2
210000003663 amniotic stem cell Anatomy 0.000 description 2
206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
230000001772 anti-angiogenic effect Effects 0.000 description 2
230000006907 apoptotic process Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
230000037444 atrophy Effects 0.000 description 2
230000005784 autoimmunity Effects 0.000 description 2
208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 description 2
229910052788 barium Inorganic materials 0.000 description 2
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000000740 bleeding effect Effects 0.000 description 2
230000008499 blood brain barrier function Effects 0.000 description 2
210000001218 blood-brain barrier Anatomy 0.000 description 2
210000004271 bone marrow stromal cell Anatomy 0.000 description 2
210000005013 brain tissue Anatomy 0.000 description 2
229960004015 calcitonin Drugs 0.000 description 2
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 2
239000011575 calcium Substances 0.000 description 2
208000015100 cartilage disease Diseases 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
208000025222 central nervous system infectious disease Diseases 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
238000002316 cosmetic surgery Methods 0.000 description 2
239000012228 culture supernatant Substances 0.000 description 2
210000000805 cytoplasm Anatomy 0.000 description 2
230000007850 degeneration Effects 0.000 description 2
230000003111 delayed effect Effects 0.000 description 2
210000004443 dendritic cell Anatomy 0.000 description 2
238000013461 design Methods 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
230000005750 disease progression Effects 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
238000004520 electroporation Methods 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000000262 estrogen Substances 0.000 description 2
108010038795 estrogen receptors Proteins 0.000 description 2
230000001747 exhibiting effect Effects 0.000 description 2
235000019197 fats Nutrition 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
210000004700 fetal blood Anatomy 0.000 description 2
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
210000003976 gap junction Anatomy 0.000 description 2
210000001035 gastrointestinal tract Anatomy 0.000 description 2
230000007045 gastrulation Effects 0.000 description 2
238000012239 gene modification Methods 0.000 description 2
238000012252 genetic analysis Methods 0.000 description 2
230000005017 genetic modification Effects 0.000 description 2
235000013617 genetically modified food Nutrition 0.000 description 2
229960002518 gentamicin Drugs 0.000 description 2
239000011521 glass Substances 0.000 description 2
239000005090 green fluorescent protein Substances 0.000 description 2
210000003709 heart valve Anatomy 0.000 description 2
208000009429 hemophilia B Diseases 0.000 description 2
230000000971 hippocampal effect Effects 0.000 description 2
239000012510 hollow fiber Substances 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
238000007654 immersion Methods 0.000 description 2
230000001506 immunosuppresive effect Effects 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000000968 intestinal effect Effects 0.000 description 2
210000001985 kidney epithelial cell Anatomy 0.000 description 2
208000032839 leukemia Diseases 0.000 description 2
208000019423 liver disease Diseases 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
201000001441 melanoma Diseases 0.000 description 2
DKHGMERMDICWDU-GHDNBGIDSA-N menaquinone-4 Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 DKHGMERMDICWDU-GHDNBGIDSA-N 0.000 description 2
239000003094 microcapsule Substances 0.000 description 2
238000001000 micrograph Methods 0.000 description 2
238000000520 microinjection Methods 0.000 description 2
230000005012 migration Effects 0.000 description 2
238000013508 migration Methods 0.000 description 2
210000000107 myocyte Anatomy 0.000 description 2
229940053128 nerve growth factor Drugs 0.000 description 2
210000003061 neural cell Anatomy 0.000 description 2
230000003988 neural development Effects 0.000 description 2
230000004770 neurodegeneration Effects 0.000 description 2
230000000955 neuroendocrine Effects 0.000 description 2
230000004766 neurogenesis Effects 0.000 description 2
230000014511 neuron projection development Effects 0.000 description 2
229920001220 nitrocellulos Polymers 0.000 description 2
238000010899 nucleation Methods 0.000 description 2
230000002188 osteogenic effect Effects 0.000 description 2
230000002018 overexpression Effects 0.000 description 2
229920002866 paraformaldehyde Polymers 0.000 description 2
210000004738 parenchymal cell Anatomy 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
208000027232 peripheral nervous system disease Diseases 0.000 description 2
230000002974 pharmacogenomic effect Effects 0.000 description 2
NTGBUUXKGAZMSE-UHFFFAOYSA-N phenyl n-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]carbamate Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(NC(=O)OC=3C=CC=CC=3)=CC=2)CC1 NTGBUUXKGAZMSE-UHFFFAOYSA-N 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
108090000102 pigment epithelium-derived factor Proteins 0.000 description 2
229920002239 polyacrylonitrile Polymers 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
230000002265 prevention Effects 0.000 description 2
VYXXMAGSIYIYGD-NWAYQTQBSA-N propan-2-yl 2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(pyrimidine-4-carbonylamino)phosphoryl]amino]-2-methylpropanoate Chemical compound CC(C)OC(=O)C(C)(C)NP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)NC(=O)c1ccncn1 VYXXMAGSIYIYGD-NWAYQTQBSA-N 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
230000005855 radiation Effects 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
230000004264 retinal detachment Effects 0.000 description 2
230000002207 retinal effect Effects 0.000 description 2
229930002330 retinoic acid Natural products 0.000 description 2
108091092562 ribozyme Proteins 0.000 description 2
230000028327 secretion Effects 0.000 description 2
208000007056 sickle cell anemia Diseases 0.000 description 2
SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
210000001082 somatic cell Anatomy 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
150000003431 steroids Chemical class 0.000 description 2
230000000638 stimulation Effects 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000000725 suspension Substances 0.000 description 2
229960001603 tamoxifen Drugs 0.000 description 2
230000008685 targeting Effects 0.000 description 2
231100000378 teratogenic Toxicity 0.000 description 2
230000003390 teratogenic effect Effects 0.000 description 2
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
230000008733 trauma Effects 0.000 description 2
230000000472 traumatic effect Effects 0.000 description 2
229960001727 tretinoin Drugs 0.000 description 2
210000005239 tubule Anatomy 0.000 description 2
239000003981 vehicle Substances 0.000 description 2
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
235000005282 vitamin D3 Nutrition 0.000 description 2
239000011647 vitamin D3 Substances 0.000 description 2
235000019143 vitamin K2 Nutrition 0.000 description 2
239000011728 vitamin K2 Substances 0.000 description 2
229940021056 vitamin d3 Drugs 0.000 description 2
208000006542 von Hippel-Lindau disease Diseases 0.000 description 2
210000004885 white matter Anatomy 0.000 description 2
JMDCRDOIPYCSCH-RPDRGXCHSA-N (2S)-3-(3,4-dihydroxyphenyl)-2-(fluoranylamino)propanoic acid Chemical compound [18F]N[C@H](C(=O)O)CC1=CC=C(O)C(O)=C1 JMDCRDOIPYCSCH-RPDRGXCHSA-N 0.000 description 1
OPCHFPHZPIURNA-MFERNQICSA-N (2s)-2,5-bis(3-aminopropylamino)-n-[2-(dioctadecylamino)acetyl]pentanamide Chemical compound CCCCCCCCCCCCCCCCCCN(CC(=O)NC(=O)[C@H](CCCNCCCN)NCCCN)CCCCCCCCCCCCCCCCCC OPCHFPHZPIURNA-MFERNQICSA-N 0.000 description 1
QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
PHPOQUFMMUKPTA-UHFFFAOYSA-N 1-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OS(=O)(=O)C(C)N(CCO)CCO PHPOQUFMMUKPTA-UHFFFAOYSA-N 0.000 description 1
KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
JHPNVNIEXXLNTR-UHFFFAOYSA-N 4-(trimethylammonio)butanoate Chemical compound C[N+](C)(C)CCCC([O-])=O JHPNVNIEXXLNTR-UHFFFAOYSA-N 0.000 description 1
101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
101710151806 72 kDa type IV collagenase Proteins 0.000 description 1
102100026802 72 kDa type IV collagenase Human genes 0.000 description 1
102100036664 Adenosine deaminase Human genes 0.000 description 1
102000055025 Adenosine deaminases Human genes 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
206010001557 Albinism Diseases 0.000 description 1
238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
201000004384 Alopecia Diseases 0.000 description 1
241000710929 Alphavirus Species 0.000 description 1
241001128034 Amphotropic murine leukemia virus Species 0.000 description 1
206010002199 Anaphylactic shock Diseases 0.000 description 1
206010002329 Aneurysm Diseases 0.000 description 1
102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
206010058298 Argininosuccinate synthetase deficiency Diseases 0.000 description 1
238000000035 BCA protein assay Methods 0.000 description 1
201000006935 Becker muscular dystrophy Diseases 0.000 description 1
208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 1
206010004659 Biliary cirrhosis Diseases 0.000 description 1
108010039209 Blood Coagulation Factors Proteins 0.000 description 1
102000015081 Blood Coagulation Factors Human genes 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000701822 Bovine papillomavirus Species 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
108091028690 C-myc mRNA Proteins 0.000 description 1
101100400452 Caenorhabditis elegans map-2 gene Proteins 0.000 description 1
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
208000005623 Carcinogenesis Diseases 0.000 description 1
206010007559 Cardiac failure congestive Diseases 0.000 description 1
102000011727 Caspases Human genes 0.000 description 1
108010076667 Caspases Proteins 0.000 description 1
201000006082 Chickenpox Diseases 0.000 description 1
206010068051 Chimerism Diseases 0.000 description 1
ULBXWWGWDPVHAO-UHFFFAOYSA-N Chlorbufam Chemical compound C#CC(C)OC(=O)NC1=CC=CC(Cl)=C1 ULBXWWGWDPVHAO-UHFFFAOYSA-N 0.000 description 1
108010005939 Ciliary Neurotrophic Factor Proteins 0.000 description 1
102100031614 Ciliary neurotrophic factor Human genes 0.000 description 1
201000011297 Citrullinemia Diseases 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
208000002330 Congenital Heart Defects Diseases 0.000 description 1
206010010317 Congenital absence of bile ducts Diseases 0.000 description 1
102000010970 Connexin Human genes 0.000 description 1
108050001175 Connexin Proteins 0.000 description 1
102000001189 Cyclic Peptides Human genes 0.000 description 1
108010069514 Cyclic Peptides Proteins 0.000 description 1
201000003883 Cystic fibrosis Diseases 0.000 description 1
102100025621 Cytochrome b-245 heavy chain Human genes 0.000 description 1
208000031124 Dementia Alzheimer type Diseases 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
102100030012 Deoxyribonuclease-1 Human genes 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
208000013558 Developmental Bone disease Diseases 0.000 description 1
208000032131 Diabetic Neuropathies Diseases 0.000 description 1
101150118728 Dlx5 gene Proteins 0.000 description 1
108010069091 Dystrophin Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
238000012286 ELISA Assay Methods 0.000 description 1
102000002322 Egg Proteins Human genes 0.000 description 1
108010000912 Egg Proteins Proteins 0.000 description 1
206010014596 Encephalitis Japanese B Diseases 0.000 description 1
102100031780 Endonuclease Human genes 0.000 description 1
108010075944 Erythropoietin Receptors Proteins 0.000 description 1
102100036509 Erythropoietin receptor Human genes 0.000 description 1
108010076282 Factor IX Proteins 0.000 description 1
108010014172 Factor V Proteins 0.000 description 1
201000003542 Factor VIII deficiency Diseases 0.000 description 1
102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
102100037362 Fibronectin Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
108700039691 Genetic Promoter Regions Proteins 0.000 description 1
208000022606 Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome Diseases 0.000 description 1
208000022461 Glomerular disease Diseases 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
208000009292 Hemophilia A Diseases 0.000 description 1
241000893570 Hendra henipavirus Species 0.000 description 1
102100035108 High affinity nerve growth factor receptor Human genes 0.000 description 1
101150068639 Hnf4a gene Proteins 0.000 description 1
101000946926 Homo sapiens C-C chemokine receptor type 5 Proteins 0.000 description 1
101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 1
101000596894 Homo sapiens High affinity nerve growth factor receptor Proteins 0.000 description 1
101000587058 Homo sapiens Methylenetetrahydrofolate reductase Proteins 0.000 description 1
101000638044 Homo sapiens Neurogenic differentiation factor 1 Proteins 0.000 description 1
101001133957 Homo sapiens Putative POU domain, class 5, transcription factor 1B Proteins 0.000 description 1
101000655352 Homo sapiens Telomerase reverse transcriptase Proteins 0.000 description 1
101000835093 Homo sapiens Transferrin receptor protein 1 Proteins 0.000 description 1
101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
208000005168 Intussusception Diseases 0.000 description 1
201000005807 Japanese encephalitis Diseases 0.000 description 1
241000710842 Japanese encephalitis virus Species 0.000 description 1
FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
102100021747 Leukemia inhibitory factor receptor Human genes 0.000 description 1
101710142062 Leukemia inhibitory factor receptor Proteins 0.000 description 1
206010067125 Liver injury Diseases 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
206010064912 Malignant transformation Diseases 0.000 description 1
208000001826 Marfan syndrome Diseases 0.000 description 1
108010000684 Matrix Metalloproteinases Proteins 0.000 description 1
102000002274 Matrix Metalloproteinases Human genes 0.000 description 1
102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
108010015302 Matrix metalloproteinase-9 Proteins 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
208000024556 Mendelian disease Diseases 0.000 description 1
NPPQSCRMBWNHMW-UHFFFAOYSA-N Meprobamate Chemical compound NC(=O)OCC(C)(CCC)COC(N)=O NPPQSCRMBWNHMW-UHFFFAOYSA-N 0.000 description 1
102100023174 Methionine aminopeptidase 2 Human genes 0.000 description 1
108090000192 Methionyl aminopeptidases Proteins 0.000 description 1
102100029684 Methylenetetrahydrofolate reductase Human genes 0.000 description 1
208000003452 Multiple Hereditary Exostoses Diseases 0.000 description 1
208000034578 Multiple myelomas Diseases 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
208000029549 Muscle injury Diseases 0.000 description 1
208000021642 Muscular disease Diseases 0.000 description 1
201000004458 Myoma Diseases 0.000 description 1
201000009623 Myopathy Diseases 0.000 description 1
206010068871 Myotonic dystrophy Diseases 0.000 description 1
108050000637 N-cadherin Proteins 0.000 description 1
108091008604 NGF receptors Proteins 0.000 description 1
208000005289 Neoplastic Cell Transformation Diseases 0.000 description 1
206010029113 Neovascularisation Diseases 0.000 description 1
208000009905 Neurofibromatoses Diseases 0.000 description 1
208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
206010030146 Oesophageal atresia Diseases 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
208000010191 Osteitis Deformans Diseases 0.000 description 1
208000004286 Osteochondrodysplasias Diseases 0.000 description 1
206010031252 Osteomyelitis Diseases 0.000 description 1
206010031264 Osteonecrosis Diseases 0.000 description 1
208000001132 Osteoporosis Diseases 0.000 description 1
206010033078 Otitis media Diseases 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
108091007960 PI3Ks Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
208000027868 Paget disease Diseases 0.000 description 1
208000016222 Pancreatic disease Diseases 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108091093037 Peptide nucleic acid Proteins 0.000 description 1
201000005702 Pertussis Diseases 0.000 description 1
201000011252 Phenylketonuria Diseases 0.000 description 1
102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
208000000474 Poliomyelitis Diseases 0.000 description 1
229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
108010039918 Polylysine Proteins 0.000 description 1
102000004257 Potassium Channel Human genes 0.000 description 1
101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 description 1
108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
102000030764 Purine-nucleoside phosphorylase Human genes 0.000 description 1
102100034145 Putative POU domain, class 5, transcription factor 1B Human genes 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108091027981 Response element Proteins 0.000 description 1
208000007014 Retinitis pigmentosa Diseases 0.000 description 1
201000000582 Retinoblastoma Diseases 0.000 description 1
241000702670 Rotavirus Species 0.000 description 1
102000001424 Ryanodine receptors Human genes 0.000 description 1
238000011579 SCID mouse model Methods 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
206010072610 Skeletal dysplasia Diseases 0.000 description 1
201000010829 Spina bifida Diseases 0.000 description 1
208000006097 Spinal Dysraphism Diseases 0.000 description 1
208000014151 Stomatognathic disease Diseases 0.000 description 1
LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
102000001435 Synapsin Human genes 0.000 description 1
108050009621 Synapsin Proteins 0.000 description 1
101710192266 Tegument protein VP22 Proteins 0.000 description 1
206010043189 Telangiectasia Diseases 0.000 description 1
206010043276 Teratoma Diseases 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
206010043395 Thalassaemia sickle cell Diseases 0.000 description 1
208000002903 Thalassemia Diseases 0.000 description 1
241000011102 Thera Species 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
102100039041 Tissue-resident T-cell transcription regulator protein ZNF683 Human genes 0.000 description 1
101710120939 Tissue-resident T-cell transcription regulator protein ZNF683 Proteins 0.000 description 1
208000008312 Tooth Loss Diseases 0.000 description 1
102000004357 Transferases Human genes 0.000 description 1
108090000992 Transferases Proteins 0.000 description 1
102100026144 Transferrin receptor protein 1 Human genes 0.000 description 1
206010052779 Transplant rejections Diseases 0.000 description 1
208000030886 Traumatic Brain injury Diseases 0.000 description 1
244000078912 Trichosanthes cucumerina Species 0.000 description 1
235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
102100026893 Troponin T, cardiac muscle Human genes 0.000 description 1
101710165323 Troponin T, cardiac muscle Proteins 0.000 description 1
101710202239 Tubulin beta-3 chain Proteins 0.000 description 1
102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 1
102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 1
102000008790 VE-cadherin Human genes 0.000 description 1
206010046980 Varicella Diseases 0.000 description 1
241000711975 Vesicular stomatitis virus Species 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
210000001766 X chromosome Anatomy 0.000 description 1
210000002593 Y chromosome Anatomy 0.000 description 1
208000003152 Yellow Fever Diseases 0.000 description 1
241000710772 Yellow fever virus Species 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
210000001789 adipocyte Anatomy 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
108700023471 alginate-polylysine-alginate Proteins 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
230000007815 allergy Effects 0.000 description 1
231100000360 alopecia Toxicity 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
208000003455 anaphylaxis Diseases 0.000 description 1
230000003872 anastomosis Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000001093 anti-cancer Effects 0.000 description 1
230000003409 anti-rejection Effects 0.000 description 1
201000003554 argininosuccinic aciduria Diseases 0.000 description 1
230000006793 arrhythmia Effects 0.000 description 1
206010003119 arrhythmia Diseases 0.000 description 1
230000003416 augmentation Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
238000007630 basic procedure Methods 0.000 description 1
210000000013 bile duct Anatomy 0.000 description 1
201000005271 biliary atresia Diseases 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
TZSMWSKOPZEMAJ-UHFFFAOYSA-N bis[(2-methoxyphenyl)methyl] carbonate Chemical compound COC1=CC=CC=C1COC(=O)OCC1=CC=CC=C1OC TZSMWSKOPZEMAJ-UHFFFAOYSA-N 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
239000003114 blood coagulation factor Substances 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000008366 buffered solution Substances 0.000 description 1
229940043253 butylated hydroxyanisole Drugs 0.000 description 1
CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
108010018828 cadherin 5 Proteins 0.000 description 1
229910001424 calcium ion Inorganic materials 0.000 description 1
230000036952 cancer formation Effects 0.000 description 1
230000005907 cancer growth Effects 0.000 description 1
238000009566 cancer vaccine Methods 0.000 description 1
229940022399 cancer vaccine Drugs 0.000 description 1
210000000234 capsid Anatomy 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
231100000504 carcinogenesis Toxicity 0.000 description 1
230000020411 cell activation Effects 0.000 description 1
230000011712 cell development Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
230000002648 chondrogenic effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
208000016532 chronic granulomatous disease Diseases 0.000 description 1
210000004240 ciliary body Anatomy 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000010367 cloning Methods 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229940096422 collagen type i Drugs 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000002354 daily effect Effects 0.000 description 1
230000034994 death Effects 0.000 description 1
210000004489 deciduous teeth Anatomy 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000000593 degrading effect Effects 0.000 description 1
210000005258 dental pulp stem cell Anatomy 0.000 description 1
230000008021 deposition Effects 0.000 description 1
210000001047 desmosome Anatomy 0.000 description 1
230000009547 development abnormality Effects 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
206010013023 diphtheria Diseases 0.000 description 1
238000007599 discharging Methods 0.000 description 1
KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
230000004821 effect on bone Effects 0.000 description 1
230000002526 effect on cardiovascular system Effects 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
230000005684 electric field Effects 0.000 description 1
206010014665 endocarditis Diseases 0.000 description 1
230000002708 enhancing effect Effects 0.000 description 1
108700004025 env Genes Proteins 0.000 description 1
230000009088 enzymatic function Effects 0.000 description 1
102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
210000002514 epidermal stem cell Anatomy 0.000 description 1
210000003237 epithelioid cell Anatomy 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
210000003617 erythrocyte membrane Anatomy 0.000 description 1
208000008929 esophageal atresia Diseases 0.000 description 1
QWUGXIXRFGEYBD-UHFFFAOYSA-M ethylmercuric chloride Chemical compound CC[Hg]Cl QWUGXIXRFGEYBD-UHFFFAOYSA-M 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
239000013604 expression vector Substances 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
229940126864 fibroblast growth factor Drugs 0.000 description 1
238000010304 firing Methods 0.000 description 1
235000019688 fish Nutrition 0.000 description 1
238000001506 fluorescence spectroscopy Methods 0.000 description 1
238000005187 foaming Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
239000012634 fragment Substances 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000030279 gene silencing Effects 0.000 description 1
230000004077 genetic alteration Effects 0.000 description 1
231100000118 genetic alteration Toxicity 0.000 description 1
208000005017 glioblastoma Diseases 0.000 description 1
231100000852 glomerular disease Toxicity 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
239000003966 growth inhibitor Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
230000005831 heart abnormality Effects 0.000 description 1
239000001307 helium Substances 0.000 description 1
229910052734 helium Inorganic materials 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
238000011134 hematopoietic stem cell transplantation Methods 0.000 description 1
230000011132 hemopoiesis Effects 0.000 description 1
231100000234 hepatic damage Toxicity 0.000 description 1
210000003897 hepatic stem cell Anatomy 0.000 description 1
208000005252 hepatitis A Diseases 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
239000005556 hormone Substances 0.000 description 1
230000004727 humoral immunity Effects 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000008073 immune recognition Effects 0.000 description 1
230000037451 immune surveillance Effects 0.000 description 1
230000034435 immune system development Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
238000003318 immunodepletion Methods 0.000 description 1
238000010185 immunofluorescence analysis Methods 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000013388 immunohistochemistry analysis Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
238000007901 in situ hybridization Methods 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
239000000411 inducer Substances 0.000 description 1
208000022760 infectious otitis media Diseases 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
208000037798 influenza B Diseases 0.000 description 1
238000002329 infrared spectrum Methods 0.000 description 1
238000011221 initial treatment Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
208000004348 intestinal atresia Diseases 0.000 description 1
208000003243 intestinal obstruction Diseases 0.000 description 1
238000010212 intracellular staining Methods 0.000 description 1
230000009545 invasion Effects 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
108020001756 ligand binding domains Proteins 0.000 description 1
210000000982 limb bud Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000010859 live-cell imaging Methods 0.000 description 1
230000008818 liver damage Effects 0.000 description 1
244000144972 livestock Species 0.000 description 1
238000002690 local anesthesia Methods 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
239000006166 lysate Substances 0.000 description 1
230000006674 lysosomal degradation Effects 0.000 description 1
230000036244 malformation Effects 0.000 description 1
230000036212 malign transformation Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
208000027202 mammary Paget disease Diseases 0.000 description 1
230000035800 maturation Effects 0.000 description 1
239000013028 medium composition Substances 0.000 description 1
210000003593 megakaryocyte Anatomy 0.000 description 1
230000034217 membrane fusion Effects 0.000 description 1
IBIKHMZPHNKTHM-RDTXWAMCSA-N merck compound 25 Chemical compound C1C[C@@H](C(O)=O)[C@H](O)CN1C(C1=C(F)C=CC=C11)=NN1C(=O)C1=C(Cl)C=CC=C1C1CC1 IBIKHMZPHNKTHM-RDTXWAMCSA-N 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
210000003584 mesangial cell Anatomy 0.000 description 1
210000001259 mesencephalon Anatomy 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
230000007102 metabolic function Effects 0.000 description 1
230000031864 metaphase Effects 0.000 description 1
239000011325 microbead Substances 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
239000013586 microbial product Substances 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000004879 molecular function Effects 0.000 description 1
LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
235000013923 monosodium glutamate Nutrition 0.000 description 1
239000004223 monosodium glutamate Substances 0.000 description 1
230000004660 morphological change Effects 0.000 description 1
206010028197 multiple epiphyseal dysplasia Diseases 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
201000006938 muscular dystrophy Diseases 0.000 description 1
231100000219 mutagenic Toxicity 0.000 description 1
230000003505 mutagenic effect Effects 0.000 description 1
YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
230000000626 neurodegenerative effect Effects 0.000 description 1
230000007472 neurodevelopment Effects 0.000 description 1
201000004931 neurofibromatosis Diseases 0.000 description 1
108010091047 neurofilament protein H Proteins 0.000 description 1
230000001272 neurogenic effect Effects 0.000 description 1
230000009689 neuronal regeneration Effects 0.000 description 1
239000003900 neurotrophic factor Substances 0.000 description 1
229940032018 neurotrophin 3 Drugs 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
231100000957 no side effect Toxicity 0.000 description 1
102000039446 nucleic acids Human genes 0.000 description 1
108020004707 nucleic acids Proteins 0.000 description 1
150000007523 nucleic acids Chemical class 0.000 description 1
230000030648 nucleus localization Effects 0.000 description 1
230000000474 nursing effect Effects 0.000 description 1
210000000956 olfactory bulb Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
230000008520 organization Effects 0.000 description 1
101710135378 pH 6 antigen Proteins 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
230000036407 pain Effects 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
208000028169 periodontal disease Diseases 0.000 description 1
230000008823 permeabilization Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
238000000053 physical method Methods 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
210000002826 placenta Anatomy 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
238000007747 plating Methods 0.000 description 1
108700004029 pol Genes Proteins 0.000 description 1
229920000656 polylysine Polymers 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
108020001213 potassium channel Proteins 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
208000023958 prostate neoplasm Diseases 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
238000003751 purification from natural source Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000002278 reconstructive surgery Methods 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
238000007634 remodeling Methods 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
238000002271 resection Methods 0.000 description 1
230000004258 retinal degeneration Effects 0.000 description 1
201000005404 rubella Diseases 0.000 description 1
108091052345 ryanodine receptor (TC 1.A.3.1) family Proteins 0.000 description 1
230000007017 scission Effects 0.000 description 1
206010039722 scoliosis Diseases 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
238000010187 selection method Methods 0.000 description 1
235000011649 selenium Nutrition 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
239000004017 serum-free culture medium Substances 0.000 description 1
208000002491 severe combined immunodeficiency Diseases 0.000 description 1
229910001961 silver nitrate Inorganic materials 0.000 description 1
229960002930 sirolimus Drugs 0.000 description 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
208000017520 skin disease Diseases 0.000 description 1
210000001057 smooth muscle myoblast Anatomy 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
235000019345 sodium thiosulphate Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
230000037351 starvation Effects 0.000 description 1
238000009168 stem cell therapy Methods 0.000 description 1
238000009580 stem-cell therapy Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
210000002504 synaptic vesicle Anatomy 0.000 description 1
230000021966 synaptic vesicle transport Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
239000008399 tap water Substances 0.000 description 1
235000020679 tap water Nutrition 0.000 description 1
208000009056 telangiectasis Diseases 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 1
229940103494 thiosalicylic acid Drugs 0.000 description 1
210000004357 third molar Anatomy 0.000 description 1
210000001578 tight junction Anatomy 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
238000012090 tissue culture technique Methods 0.000 description 1
230000000451 tissue damage Effects 0.000 description 1
231100000827 tissue damage Toxicity 0.000 description 1
208000037816 tissue injury Diseases 0.000 description 1
210000003014 totipotent stem cell Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
229940031572 toxoid vaccine Drugs 0.000 description 1
210000003437 trachea Anatomy 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000003146 transient transfection Methods 0.000 description 1
230000032258 transport Effects 0.000 description 1
238000011269 treatment regimen Methods 0.000 description 1
239000003656 tris buffered saline Substances 0.000 description 1
210000002993 trophoblast Anatomy 0.000 description 1
230000005740 tumor formation Effects 0.000 description 1
230000004614 tumor growth Effects 0.000 description 1
230000001875 tumorinhibitory effect Effects 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
210000003606 umbilical vein Anatomy 0.000 description 1
230000004143 urea cycle Effects 0.000 description 1
230000002485 urinary effect Effects 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
230000002792 vascular Effects 0.000 description 1
230000028973 vesicle-mediated transport Effects 0.000 description 1
230000029812 viral genome replication Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
210000001325 yolk sac Anatomy 0.000 description 1